Norwood EyeCare Commences Epi-LASIK U.S. Prospective Study.MELBOURNE, Australia -- Norwood Abbey Limited (ASX ASX See: Australian Stock Exchange :NAL NAL National Agricultural Library (Agricultural Research Service; US Department of Agriculture) NAL New American Library NAL National Accelerator Laboratory NAL National Aerospace Laboratory (Japan) ): Key Points: --Study being conducted by leading U.S. ophthalmic surgeons - Dr. Marguerite McDonald, Dr. Daniel Durrie and Dr. Lee Shahinian --Study will bring together two innovative technologies - Epi-LASIK and wavefront Noun 1. wavefront - (physics) an imaginary surface joining all points in space that are reached at the same instant by a wave propagating through a medium wave front diagnostics --U.S. study to measure post-operative comfort, visual recovery and wavefront measurement Norwood Abbey Limited (ASX:NAL) subsidiary, Norwood EyeCare, the innovative ophthalmic devices company announced it has begun a 3-month study of post-operative comfort, visual recovery and wave-front guided custom ablation with its Centurion SES(TM) Epikeratome with EpiEdge(TM) for Epi-LASIK in surgical treatment of myopia myopia: see nearsightedness. . Marguerite B. McDonald, M.D., F.A.C.S., is the principal investigator and medical monitor for the study. Daniel D. Durrie, M.D., and Lee Shahinian, M.D., are clinical investigators. "Epi-LASIK and wavefront diagnostics address two key complications such as stromal Stromal A type of tissue that is associated with the support of an organ. Mentioned in: Wilms' Tumor flap complications and higher order aberrations associated with current refractive refractive capacity to refract light. refractive error a difference between the focal length of the cornea and lens, and the length of the eye, resulting in myopia or hyperopia. laser procedures," explained Dr. Marguerite B. McDonald. "In this exciting study, we will examine how the coupling of the two technologies may impact visual outcomes." Unlike conventional LASIK LASIK laser-assisted in-situ keratomileusis. LA·SIK n. Eye surgery in which the surface of the cornea is reshaped using a laser, performed to correct certain refractive disorders such as myopia. , in which a sharp blade is used to make a stromal flap in the cornea, the Epikeratome employs a non-sharp plastic separator to gently lift a hinged sheet of intact epithelium from the cornea. Norwood's bladeless Epi-LASIK technology provides the benefits of LASIK but is designed to reduce or eliminate stromal flap complications as well as the risk of LASIK-induced dry eye, potentially facilitating faster recovery and less postoperative pain. Patients for whom LASIK is not advised -- such as those with thin corneas or dry eye -- or who have had concerns about potential LASIK side effects are strong candidates for Epi-LASIK. A maximum of 35 patients (up to 70 procedures) will be enrolled at each of the three U.S. study sites. The treatments will be either bilateral or single eye, and if bilateral, both eyes will be treated at the same time. Only patients who have not previously had ocular surgery will be included. In addition to a comprehensive preoperative evaluation, patients will be examined one day postoperative until re-epithelialization occurs; at 3 to 6 weeks postoperative; and at 10 to 15 weeks postoperative. Measures of post-operative comfort, visual recovery will be taken and wavefront measurement will be performed. Dr. McDonald, Norwood EyeCare's Global Medical Advisor and a member of its Medical and Scientific Advisory Board (MSAB MSAB Minnesota State Arts Board MSAB Municipal Services Appeals Board MSAB Multi-National Security Accreditation Board ), is clinical professor of ophthalmology at Tulane University, a pioneer in laser surgery and former president of the American Society of Cataract and Refractive Surgery. Dr. Daniel Durrie is director of refractive surgery services at the University of Kansas The University of Kansas (often referred to as KU or just Kansas) is an institution of higher learning in Lawrence, Kansas. The main campus resides atop Mount Oread. Medical Center and Medical Advisor for Norwood EyeCare. Dr. Lee Shahinian, a member of Norwood's MSAB, is with the Peninsula Laser Eye Medical Group, Mountain View, California For the census-designated place, see Mountain View, Contra Costa County, California. For other places called "Mountain View", see . Mountain View is a city in Santa Clara County, in the U.S. state of California. The city gets its name from the views of the Santa Cruz Mountains. and is associate clinical professor of ophthalmology at Stanford University. About Norwood EyeCare Norwood EyeCare is a Norwood Abbey Limited Company. Norwood Abbey is a publicly listed medical technology company based in Melbourne, Australia and traded on both the Australian and the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on stock exchanges. For further information on Norwood EyeCare, visit www.norwoodeyecare.com. Norwood Abbey specializes in developing and commercializing innovative projects and technologies that address significant unmet needs in the medical industry. The Company has two business segments: Norwood Devices (EyeCare and Drug Delivery) and Norwood Immunology. Norwood's Drug Delivery technology platforms can be applied to a range of potential applications, from pain management and metabolic diseases to vaccinations. Norwood Immunology is aimed at boosting the immune system of patients, enabling them to fight infection and better cope with treatments where the immune system is compromised. This technology has application in almost all diseases affecting the immune system, including cancer, viral infections and autoimmune disorders. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion